MONEY

Analyst bullish on Stoke Therapeutics stock following key epilepsy drug data

Tomas Kauer - ModeratorTomas Kauer - Moderator
Sep 11, 2024 - 20:00
Analyst bullish on Stoke Therapeutics stock following key epilepsy drug data
Read More

Tags:

Previous Article

SciSparc extends $1.85 million loan to Automax

Next Article

Pope reminds young people they are ‘life, hope and future’

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Tomas Kauer - Moderator
Tomas Kauer - Moderator

Related Posts

RENN Fund CEO Murray Stahl buys shares worth $2,574

RENN Fund CEO Murray Stahl buys shares worth $2,574

Tomas Kauer - Mode... Oct 3, 2024

STOXX 600 hits record high on China-driven rally, set for weekly gains

STOXX 600 hits record high on China-driven rally, set f...

Tomas Kauer - Mode... Sep 27, 2024

CI Financial Announces Substantial Issuer Bid Price Increase and Related Extension

CI Financial Announces Substantial Issuer Bid Price Inc...

Tomas Kauer - Mode... Sep 19, 2024